NCT06902818View on ClinicalTrials.gov

The Study Compare and Evaluate the Safety and PK Data of a Single Dose Administration of 'AD-115A' or 'AD-1151'

PHASE1CompletedINTERVENTIONAL

Enrollment

46

Participants

Timeline

Start Date

March 21, 2025

Primary Completion Date

April 25, 2025

Study Completion Date

May 8, 2025

Conditions

Gastric Ulcer

Interventions

DRUG

AD-115A, AD-1151

AD-115A , AD-1151 Oral Tablet

Trial Locations (1)

Unknown

H PLUS YANGJI HOSPITAL, Seoul,, Seoul

All Listed Sponsors

lead

Addpharma Inc.

INDUSTRY